These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 18492096

  • 1. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
    Costa LJ, Feldman AL, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Ansell SM.
    Br J Haematol; 2008 Jul; 142(3):404-12. PubMed ID: 18492096
    [Abstract] [Full Text] [Related]

  • 2. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
    Thieblemont C, Briere J, Mounier N, Voelker HU, Cuccuini W, Hirchaud E, Rosenwald A, Jack A, Sundstrom C, Cogliatti S, Trougouboff P, Boudova L, Ysebaert L, Soulier J, Chevalier C, Bron D, Schmitz N, Gaulard P, Houlgatte R, Gisselbrecht C.
    J Clin Oncol; 2011 Nov 01; 29(31):4079-87. PubMed ID: 21947824
    [Abstract] [Full Text] [Related]

  • 3. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM.
    J Clin Oncol; 2008 Oct 01; 26(28):4587-94. PubMed ID: 18662967
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
    Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM.
    Hum Pathol; 2008 Jun 01; 39(6):875-84. PubMed ID: 18440593
    [Abstract] [Full Text] [Related]

  • 5. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR, Ansell SM.
    Br J Haematol; 2008 Oct 01; 143(2):268-73. PubMed ID: 18699848
    [Abstract] [Full Text] [Related]

  • 6. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.
    Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, Lee NR, Kwak JY, Park BH, Park HS, Chung MJ, Kang MJ, Lee DG, Kim HS, Shim H, Moon WS.
    Am J Surg Pathol; 2008 Oct 01; 32(10):1523-31. PubMed ID: 18724249
    [Abstract] [Full Text] [Related]

  • 7. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
    Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW.
    Histopathology; 2008 Aug 01; 53(2):205-17. PubMed ID: 18752503
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of immunohistochemical classification of diffuse large B-cell lymphoma into germinal center B-cell and non-germinal center B-cell subtypes.
    Saad AA, Awed NM, Abdel-Hafeez ZM, Kamal GM, Elsallaly HM, Alloub AI.
    Saudi Med J; 2010 Feb 01; 31(2):135-41. PubMed ID: 20174727
    [Abstract] [Full Text] [Related]

  • 9. Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin?
    Laszlo D, Pruneri G, Andreola G, Radice D, Calabrese L, Rafaniello PR, Nassi L, Sammassimo S, Alietti A, Agazzi A, Vanazzi A, Martinelli G.
    Int J Surg Pathol; 2011 Aug 01; 19(4):417-24. PubMed ID: 19793830
    [Abstract] [Full Text] [Related]

  • 10. Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.
    Hernandez-Ilizaliturri FJ, Deeb G, Zinzani PL, Pileri SA, Malik F, Macon WR, Goy A, Witzig TE, Czuczman MS.
    Cancer; 2011 Nov 15; 117(22):5058-66. PubMed ID: 21495023
    [Abstract] [Full Text] [Related]

  • 11. Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.
    Larouche JF, Berger F, Chassagne-Clément C, Ffrench M, Callet-Bauchu E, Sebban C, Ghesquières H, Broussais-Guillaumot F, Salles G, Coiffier B.
    J Clin Oncol; 2010 Apr 20; 28(12):2094-100. PubMed ID: 20308668
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype".
    Kusumoto S, Kobayashi Y, Sekiguchi N, Tanimoto K, Onishi Y, Yokota Y, Watanabe T, Maeshima AM, Ishida T, Inagaki H, Matsuno Y, Ueda R, Tobinai K.
    Am J Surg Pathol; 2005 Aug 20; 29(8):1067-73. PubMed ID: 16006802
    [Abstract] [Full Text] [Related]

  • 14. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
    Ye ZY, Cao YB, Lin TY, Lin HL.
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct 20; 36(10):654-9. PubMed ID: 18194597
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
    van Galen JC, Muris JJ, Giroth CP, Vos W, Ossenkoppele GJ, Meijer CJ, Oudejans JJ.
    Histopathology; 2008 Apr 20; 52(5):578-84. PubMed ID: 18312353
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ, Meijer CJ, Vos W, van Krieken JH, Jiwa NM, Ossenkoppele GJ, Oudejans JJ.
    J Pathol; 2006 Apr 20; 208(5):714-23. PubMed ID: 16400625
    [Abstract] [Full Text] [Related]

  • 18. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.
    Hoeller S, Schneider A, Haralambieva E, Dirnhofer S, Tzankov A.
    Histopathology; 2010 Jul 20; 57(1):73-80. PubMed ID: 20579129
    [Abstract] [Full Text] [Related]

  • 19. Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.
    Kewalramani T, Zelenetz AD, Teruya-Feldstein J, Hamlin P, Yahalom J, Horwitz S, Nimer SD, Moskowitz CH.
    Br J Haematol; 2006 Jul 20; 134(2):202-7. PubMed ID: 16759221
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of immunohistochemistry in identification of prognostically important subgroups (GCB and ABC) in a heterogeneous group of diffuse large B-cell lymphomas--a review article.
    Jabłońska J, Jesionek-Kupnicka D.
    Pol J Pathol; 2008 Jul 20; 59(3):121-7. PubMed ID: 19097355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.